Sixty seconds on . . . TrialsTrackerBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5990 (Published 08 November 2016) Cite this as: BMJ 2016;355:i5990
- Gareth Iacobucci
- The BMJ
What’s this? A new app for cycling enthusiasts?
Guess again. It’s actually a new automated tracking service to monitor clinical trials. More specifically, it aims to shine a light on the drug companies and universities that aren’t publishing their trial results.
What’s its verdict?
Pretty damning, overall. The tracker (trialstracker.ebmdatalab.net), developed by academics from Oxford University and some of the key players in the AllTrials campaign (www.alltrials.net), found that 45% of all trials …